Advertisement
UK markets close in 6 hours 31 minutes
  • FTSE 100

    8,106.96
    +28.10 (+0.35%)
     
  • FTSE 250

    19,811.27
    +209.29 (+1.07%)
     
  • AIM

    756.01
    +2.89 (+0.38%)
     
  • GBP/EUR

    1.1661
    +0.0004 (+0.04%)
     
  • GBP/USD

    1.2526
    +0.0015 (+0.12%)
     
  • Bitcoin GBP

    51,369.69
    +401.51 (+0.79%)
     
  • CMC Crypto 200

    1,389.61
    -6.93 (-0.50%)
     
  • S&P 500

    5,048.42
    -23.21 (-0.46%)
     
  • DOW

    38,085.80
    -375.12 (-0.98%)
     
  • CRUDE OIL

    83.74
    +0.17 (+0.20%)
     
  • GOLD FUTURES

    2,361.10
    +18.60 (+0.79%)
     
  • NIKKEI 225

    37,934.76
    +306.28 (+0.81%)
     
  • HANG SENG

    17,651.15
    +366.61 (+2.12%)
     
  • DAX

    18,058.54
    +141.26 (+0.79%)
     
  • CAC 40

    8,045.15
    +28.50 (+0.36%)
     

Reckitt Benckiser Group plc Just Missed EPS By 6.3%: Here's What Analysts Think Will Happen Next

As you might know, Reckitt Benckiser Group plc (LON:RKT) recently reported its yearly numbers. Revenues of UK£14b were in line with forecasts, although statutory earnings per share (EPS) came in below expectations at UK£3.25, missing estimates by 6.3%. The analysts typically update their forecasts at each earnings report, and we can judge from their estimates whether their view of the company has changed or if there are any new concerns to be aware of. We've gathered the most recent statutory forecasts to see whether the analysts have changed their earnings models, following these results.

View our latest analysis for Reckitt Benckiser Group

earnings-and-revenue-growth
earnings-and-revenue-growth

Taking into account the latest results, the consensus forecast from Reckitt Benckiser Group's 16 analysts is for revenues of UK£14.9b in 2023, which would reflect a reasonable 3.3% improvement in sales compared to the last 12 months. Statutory earnings per share are predicted to accumulate 3.1% to UK£3.36. Yet prior to the latest earnings, the analysts had been anticipated revenues of UK£14.8b and earnings per share (EPS) of UK£3.41 in 2023. The consensus analysts don't seem to have seen anything in these results that would have changed their view on the business, given there's been no major change to their estimates.

ADVERTISEMENT

It will come as no surprise then, to learn that the consensus price target is largely unchanged at UK£68.11. That's not the only conclusion we can draw from this data however, as some investors also like to consider the spread in estimates when evaluating analyst price targets. There are some variant perceptions on Reckitt Benckiser Group, with the most bullish analyst valuing it at UK£80.00 and the most bearish at UK£49.75 per share. There are definitely some different views on the stock, but the range of estimates is not wide enough as to imply that the situation is unforecastable, in our view.

These estimates are interesting, but it can be useful to paint some more broad strokes when seeing how forecasts compare, both to the Reckitt Benckiser Group's past performance and to peers in the same industry. The period to the end of 2023 brings more of the same, according to the analysts, with revenue forecast to display 3.3% growth on an annualised basis. That is in line with its 3.2% annual growth over the past five years. Juxtapose this against our data, which suggests that other companies (with analyst coverage) in the industry are forecast to see their revenues grow 3.3% per year. It's clear that while Reckitt Benckiser Group's revenue growth is expected to continue on its current trajectory, it's only expected to grow in line with the industry itself.

The Bottom Line

The most obvious conclusion is that there's been no major change in the business' prospects in recent times, with the analysts holding their earnings forecasts steady, in line with previous estimates. They also reconfirmed their revenue estimates, with the company predicted to grow at about the same rate as the wider industry. There was no real change to the consensus price target, suggesting that the intrinsic value of the business has not undergone any major changes with the latest estimates.

Following on from that line of thought, we think that the long-term prospects of the business are much more relevant than next year's earnings. At Simply Wall St, we have a full range of analyst estimates for Reckitt Benckiser Group going out to 2025, and you can see them free on our platform here..

And what about risks? Every company has them, and we've spotted 1 warning sign for Reckitt Benckiser Group you should know about.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Join A Paid User Research Session
You’ll receive a US$30 Amazon Gift card for 1 hour of your time while helping us build better investing tools for the individual investors like yourself. Sign up here